Subscribe To
IRMD / IRadimed: Revise To Buy With Exceptional Incremental ROIC In Q4
IRMD News
By Zacks Investment Research
September 8, 2023
Top 3 Profitable Stocks to Buy Now Using Net Income Ratio
iRadimed (IRMD), PulteGroup (PHM) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio. more_horizontal
By GlobeNewsWire
September 6, 2023
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will more_horizontal
By Zacks Investment Research
August 30, 2023
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
iRadimed (IRMD) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is more_horizontal
By Zacks Investment Research
August 11, 2023
iRadimed (IRMD) Is a Great Choice for 'Trend' Investors, Here's Why
iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It i more_horizontal
By Zacks Investment Research
June 27, 2023
iRadimed (IRMD) is on the Move, Here's Why the Trend Could be Sustainable
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that more_horizontal
By Zacks Investment Research
June 8, 2023
Recent Price Trend in iRadimed (IRMD) is Your Friend, Here's Why
iRadimed (IRMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that more_horizontal
By Seeking Alpha
May 8, 2023
IRadimed Corporation (IRMD) Q1 2023 Earnings Call Transcript
IRadimed Corporation (NASDAQ:IRMD ) Q1 2023 Earnings Conference Call May 4, 2023 11:00 AM ET Company Participants Roger Susi - President and Chief Exe more_horizontal
By Zacks Investment Research
May 4, 2023
IRadimed (IRMD) Surpasses Q1 Earnings and Revenue Estimates
IRadimed (IRMD) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earning more_horizontal